Rahasson Ager, PhD, earned his doctoral degree in Biological Sciences from the University of California, Irvine. Before joining Pfizer, he spent several years as a bench scientist and instructor, gaining hands‑on research experience and a strong foundation in scientific communication. He joined Pfizer in 2021 as a Field Medical Director in Rare Hematology, where he provides requested medical information on Pfizer medicines and serves as a scientific resource to the healthcare community. During his time at Pfizer, Dr. Ager has contributed to multiple product launches in the hematology space and helped develop novel approaches to scientific exchange that support education and training in a rapidly evolving treatment landscape. He brings a blend of scientific expertise, communication skills, and passion for medical education to his role.